ArticleVirchows Archiv : an international journal of pathology2021

Assessment of HER2 using the 2018 ASCO/CAP guideline update for invasive breast cancer: a critical look at cases classified as HER2 2+ by immunohistochemistry.

Valerie J Taylor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.